Search

Your search keyword '"Pyrans toxicity"' showing total 282 results

Search Constraints

Start Over You searched for: Descriptor "Pyrans toxicity" Remove constraint Descriptor: "Pyrans toxicity"
282 results on '"Pyrans toxicity"'

Search Results

1. Bioavailability profiling shows differences in OA, DTX1 and DTX2 toxins that justify their toxicity.

2. Analysis of omarigliptin forced degradation products by ultra-fast liquid chromatography, mass spectrometry, and in vitro toxicity assay.

3. Reductive stress and cytotoxicity in the swollen river mussel (Unio tumidus) exposed to microplastics and salinomycin.

4. Okadaic Acid Is at Least as Toxic as Dinophysistoxin-1 after Repeated Administration to Mice by Gavage.

5. In Vitro Interactions between Okadaic Acid and Rat Gut Microbiome.

6. RIFM fragrance ingredient safety assessment, tetrahydro-6-(3-pentenyl)-2H-pyran-2-one, CAS Registry Number 32764-98-0.

7. Discovery of Novel Dihydrothiopyrano[4,3- d ]pyrimidine Derivatives as Potent HIV-1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles.

8. Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents.

9. Phytochemical and pharmacological properties of asperuloside, a systematic review.

10. RIFM fragrance ingredient safety assessment, 2,2,6-trimethyl-6-vinyltetrahydropyran, CAS registry number 7392-19-0.

11. Benchmark dose analyses of γH2AX and pH3 endpoints for quantitative comparison of in vitro genotoxicity potential of lipophilic phycotoxins.

12. Paederus dermatitis - A bibliometric analysis of an emerging disease in travelers.

13. RIFM fragrance ingredient safety assessment, tetrahydro-2-methyl-4-methylene-6-phenyl-2H-pyrane, CAS Registry number 30310-41-9.

14. Characterization of scallop midgut gland certified reference material for quantification of diarrhetic shellfish toxins.

15. RIFM fragrance ingredient safety assessment, 2-isobutyl-4-methyltetrahydro-2H-pyran-4-ol, CAS registry number 63500-71-0.

16. Azaspiracids Increase Mitochondrial Dehydrogenases Activity in Hepatocytes: Involvement of Potassium and Chloride Ions.

17. Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells.

18. Effects of a spiroketal compound Peniciketal A and its molecular mechanisms on growth inhibition in human leukemia.

19. Salinomycin decreases feline sarcoma and carcinoma cell viability when combined with doxorubicin.

20. Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.

21. Determination of the Environmental Pollution Potential of Some Herbicides by the Assessment of Cytotoxic and Genotoxic Effects on Allium cepa .

22. Protective effects of taurine against inflammation, apoptosis, and oxidative stress in brain injury.

23. Cytotoxicity of anticancer candidate salinomycin and identification of its metabolites in rat cell cultures.

25. Interlaboratory comparison of liquid chromatography-tandem mass spectrometry quantification of diarrhetic shellfish toxins in scallop midgut glands.

26. Comparative toxicity of dinophysistoxin-1 and okadaic acid in mice.

27. Harpagoside-induced anaphylactic reaction in an IgE-independent manner both in vitro and in vivo.

28. Synthesis and biological evaluation of 20-epi-amino-20-deoxysalinomycin derivatives.

29. Whole genome mRNA transcriptomics analysis reveals different modes of action of the diarrheic shellfish poisons okadaic acid and dinophysis toxin-1 versus azaspiracid-1 in Caco-2 cells.

30. Toxic equivalency factors (TEFs) after acute oral exposure of azaspiracid 1, -2 and -3 in mice.

31. Paederus dermatitis outbreak in Luanda City, Angola.

32. Palytoxin congeners.

33. Toxic Action Reevaluation of Okadaic Acid, Dinophysistoxin-1 and Dinophysistoxin-2: Toxicity Equivalency Factors Based on the Oral Toxicity Study.

34. Aruncin B: Synthetic Studies, Structural Reassignment and Biological Evaluation.

35. Embryotoxic effects of dissolved okadaic acid on the development of Longfin yellowtail Seriola rivoliana.

36. New 3-alkylpyridine marine alkaloid analogues as promising antitumor agents against the CD44 +/high /CD24 -/low subset of triple-negative breast cancer cell line.

37. Paederus dermatitis.

38. Characterization of the dinophysistoxin-2 acute oral toxicity in mice to define the Toxicity Equivalency Factor.

39. Risk Assessment via Metabolism and Cell Growth Inhibition in a HepG2/C3A Cell Line Upon Treatment with Arpadol and its Active Component Harpagoside.

40. Sublethal doses of dinophysistoxin-1 and okadaic acid stimulate secretion of inflammatory factors on innate immune cells: Negative health consequences.

41. Population and life-stage-specific effects of two herbicide formulations on the aquatic development of European common frogs (Rana temporaria).

42. Differences in Antiproliferative Activity Between Salinomycin-AZT Conjugates Obtained via 'Click' and Esterification Reactions.

43. Structure-Activity Relationship Studies Using Natural and Synthetic Okadaic Acid/Dinophysistoxin Toxins.

44. Investigation of the genotoxic potential of the marine biotoxins azaspiracid 1-3.

45. Antitumor activities of biscoumarin and dihydropyran derivatives.

46. Upregulation of p27 cyclin-dependent kinase inhibitor and a C-terminus truncated form of p27 contributes to G1 phase arrest.

47. Modulation of CYP3A4 activity alters the cytotoxicity of lipophilic phycotoxins in human hepatic HepaRG cells.

48. Effect of the industrial canning on the toxicity of mussels contaminated with diarrhetic shellfish poisoning (DSP) toxins.

49. Stereochemical Studies of the Karlotoxin Class Using NMR Spectroscopy and DP4 Chemical-Shift Analysis: Insights into their Mechanism of Action.

50. [Vesicular contact dermatitis due to Paederus in Cameroon and review of the literature].

Catalog

Books, media, physical & digital resources